Search
Document
Mathews - Successful treatment of a calcified CTO
Case study: successful treatment of a calcified CTO with Dr. S. Jay Mathews
Document
Turbo-Elite Sinha case study
Case study: recanalization of the right distal posterior tibial artery with Dr. Shantanu Sinha
Document
EXCITE clinical trial abstract
Excimer laser randomized controlled study for the treatment of femoropopliteal in-stent restenosis
Document
Philips Volcano Chronic Venous Disease (CVD): Early Diagnosis Can Lead to Better Results
Chronic Venous Disease or CVD occurs when the blood in your legs cannot flow back to your heart. When this happens, pooling blood can raise pressure in your veins, causing a range of problems.
Document
Phoenix Atherectomy System ATK BTK Poster
This document is a large poster showing the Phoenix Atherectomy system for above and below the knee.
Document
Steinkamp datasheet
To evaluate the safety and long-term results after laser and angioplasty of short occlusions of the SFA
Document
Schmidt 2 year Real-World registry
Drug-coated balloons for complex femoropopliteal lesions: two-year results of a real-world registry
Document
IVUS aortic measurements worksheet
This document is a notepad for tracking IVUS case measurements in an aortic case and used for physician dictation.
Document
Phoenix 2.2mm Deflecting Catheter Now Available in 6F
The Phoenix 2.2 mm deflecting catheter offers the latest innovation of front cutting mechanical atherectomy tools in the Phoenix atherectomy family. The newest Phoenix can create lumens 82% greater in size than the previous generation.
Document
Turbo-Elite case Nagesetty
Case study: Recanalization of a CTO in the right SFA, popliteal and peroneal arteries with Dr. Rajiv Nagesetty
Document
Philips Volcano Pioneer Plus: IVUS-guided Re-entry Catheter Quick Reference
Step-by-step procedure and troubleshooting guide on prepping the Philips Volcano Pioneer Plus catheter system.
Document
Philips Clinical Data: IVUS Changed 76% of AV Access Graft Treatment Plans
Clinical data shows that IVUS changed 76% of AV access graft treatment plans.